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SUMMARY & CONCLUSIONS 
Despite over half a century of manned space flight, the 
space flight community is only now coming to fully assess the 
short and long term medical dangers of exposure to reduced 
gravity environments. Further, as new manned spacecraft are 
designed and with the advent of commercial flight capabilities 
to the general public, a full understanding of medical risk 
becomes even more critical for maintaining and understanding 
mission safety and crew health. To address these critical 
issues, the National Aeronautics and Space Administration 
(NASA) Human Research Program (HRP) has begun to 
address the medical hazards with a formalized risk 
management approach by effectively identifying and 
attempting to mitigate acute and chronic medical risks to 
manned space flight. 
This paper describes NASA Glenn Research Center’s 
(GRC) efforts to develop a systematic methodology to assess 
the likelihood of in-flight medical conditions. Using a 
probabilistic approach, medical risks are assessed using well 
established and accepted biomedical and human performance 
models in combination with fundamentally observed data that 
defines the astronauts’ physical conditions, environment and 
activity levels. Two different examples of space flight risk are 
used to show the versatility of our approach and how it 
successfully integrates disparate information to provide HRP 
decision makers with a valuable source of information which 
is otherwise lacking.  
INTRODUCTION 
The identification of in-flight medical risk in astronauts is 
usually assessed in two ways. The first is when the medical 
event has been observed to occur in a previous space flight. 
In-flight nausea and headaches are examples of frequently 
occurring conditions requiring medical attention. Likelihood 
of occurrence and clinical outcome of these events during 
future missions can be derived from the rate and impact of the 
medical event’s occurrence during prior missions. The second 
way is from informed, expert opinion identification of 
potential medical events, even if such events have not been 
observed in US astronauts during a space mission. Examples 
of these would be a skeletal fracture and the presentation of a 
renal stone leading to renal colic. The likelihood in these later 
cases can sometimes be estimated from terrestrial data, 
provided appropriate analog populations are available. 
Unfortunately this is not always feasible, especially when 
gravity or other flight conditions play an important role in the 
clinical scenario.  
One of the more advanced tools employed by HRP to 
assess the relative impact of medical events to the crew and 
mission is the Integrated Medical Model (IMM) [1]. IMM is a 
probabilistic, simulation-based tool designed to help determine 
the relative risk associated with medical conditions that could 
occur in space and to optimize mitigations tools, such as the in 
flight medical kit. IMM utilizes probabilistic risk assessment 
(PRA) methods in combination with the best available 
evidence and current understanding of medical outcomes to 
predict the rate of occurrence and the resources needed for a 
successful response to an in-flight medical event.  
IMM’s primary forecast methodology is insufficient for 
events that have not yet occurred in space, but are still 
considered a potential hazard to space flight. In this case, the 
IMM model relies on an external analysis based on more 
fundamental observations and physical principles. A team at 
NASA GRC supports IMM by developing these models that 
forecast medical event likelihood from first principle and root 
cause information. To accomplish this task the IMM team at 
NASA GRC has developed an approach that utilizes well 
established PRA methods from engineering in combination 
with the evolving techniques in biomechanics, physiology and 
human performance modeling to assess the likelihood of 
specific medical events. The methodology is described in 
detail and implementation is illustrated in two important 
clinical scenarios: wrist fracture and sleep disruption requiring 
medical intervention. 
1 APPROACH 
The approach employed at NASA GRC increases the 
fidelity of IMM by integrating probabilistic analysis with 
deterministic models. This approach, new to the medical field, 
takes its application direction from many engineering fields, 
including fault tree analysis, simulation-based PRA and 
deterministic model uncertainty analysis. The unique aspect is 
how these techniques are integrated with the astronauts’ 
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overall condition to estimate the likelihood of injury, 
physiological system failure or environmental impact on the 
astronaut.  
The approach to developing a model of medical event 
likelihood in the space environment, in the absence of directly 
observed event occurrences, proceeds along the following 
general steps: 
 
1) A clinical event of concern is identified 
2) The space mission parameters that place the clinical event 
in context are defined from medical operations personnel  
3) A thorough literature review is performed to identify: 
a) The medical, environmental and performance 
parameters critical to defining the process of the 
medical event. 
b) The primary metrics that define the occurrence of the 
medical event. 
c) Biomechanics, physiology or performance 
deterministic models that most effectively integrate 
the contributing parameters in the calculation of the 
primary metrics. 
4) Data from the literature and from in-flight observed 
conditions are used to define population distributions for 
each of the medical, environmental and performance 
parameters.  
5) Information from 2- 4 is used to develop a PRA (Monte 
Carlo)  model that utilizes the deterministic model 
identified in 3c as a fundamental integrating mechanism 
to provide the link between observed medical parameters 
and the primary metrics. 
 
From an engineering perspective, the above would serve 
to provide substantial insight into the likelihood of the medical 
risk provided well defined thresholds of the primary metrics 
that define when the medical event occurs can be established. 
Unfortunately, the current understanding of human physiology 
and performance is not as well defined as failure modes of 
engineering materials and mechanisms, leading to an 
extensive uncertainty in the occurrence thresholds. It is 
necessary to take additional steps to assess the probability of 
medical event occurrence from our estimates of the integrated 
metrics describing the medical events. This is most often 
performed using logistic regression to generate functional 
transformations of the primary metric to a probability of 
occurrence. Once addressed in this manner, the output of the 
model is a probability density function (PDF) describing the 
estimated number of events per-mission or the most likely 
probability of occurrence within the mission time frame, with 
associated uncertainty as defined by the data and model 
structure. 
2 METHODOLOGY AND APPLICATION 
When addressing a particular medical event sequence, 
augmentation to the general approach structure is required to 
accommodate the unique aspects of the specific problem. The 
team at NASA GRC has been particularly successful in 
addressing injury modalities such as bone fracture [2] on 
planetary missions. Here we present two examples of how our 
general approach was applied to specific medical event 
analyses. The first is an analysis of the probability of wrist 
fracture on the International Space Station (ISS). The second 
is prediction of the rate of medication use to combat the 
effects of circadian sleep disruption during space flight.  
2.1 Wrist fracture 
There is a legitimate concern with regard to skeletal bone 
fracture during space missions. A bone fracture can be 
considered a structural failure of the bone that occurs when the 
load placed upon the bone exceeds its structural strength [3]. 
Apparent bone strength is dependent on several factors 
including mineral content, prior microdamage, geometry, 
architecture, age and the nature of the applied load [4]. 
Loading that exceeds the strength of the bone can occur during 
an accident where a high impact load is experienced. The 
fracture risk index (FRI) is the ratio of the apparent bone 
strength to the skeletal loading. A low FRI indicates a low 
probability of fracture, while a high FRI (>1) indicates a 
fracture is almost certain [5].  
Unexpected or off nominal events, exacerbated by the 
state of an astronauts weakened bones due to spaceflight 
induced loss of bone mineral density [6], resulting in fracture, 
are a real and present danger to space flight success. 
Additionally, space missions are severely constrained in 
resources, and by their very nature, provide limited access to 
medical care. This can have a serious impact and lead to loss 
of mission or crew member. Since the possibility of fracture 
exists and the impact to the mission could be substantial, it is 
crucial to quantify the risk of bone fracture during space 
exploration missions so that mitigation strategies can be 
engineered.  
Previous efforts at NASA GRC to quantify bone fracture 
risk on moon and Mars missions have illustrated that, while 
substantial bone mineral can be lost at load bearing locations, 
it is the wrist which has the highest probability of fracture due 
to forceful impacts such as falls [2]. The likelihood of wrist 
fracture during an ISS mission was also assessed. Our general 
modeling approach for medical events was applied to address 
wrist loading during a push off, impact or other sudden 
deceleration involving the wrist and shoulder after translation 
across the ISS cabin. The following steps outline the model:  
 
1) Determine the appropriate representation of the dynamic 
response to external loading for our application. Estimate 
the skeletal strength at the wrist for this situation from  
literature data. 
2) Determine the skeletal loading from a mass-spring-
damper, biomechanical model of the wrist, arm and 
shoulder. Modulate loading with specifics conditions 
related to the ISS environment. 
3) Estimate the probability of loading event occurrence 
during each mission day, based on the incidence rate of 
ISS translations, from observed data from ISS mission 
history. 
4) Develop a transfer function that translates FRI to a 
probability of fracture, using observational, clinical data 
of terrestrial wrist fracture. 
5) With a Monte Carlo simulation, develop a PDF of the 
probability of a loading event and a PDF of the 
probability of fracture from the loading event. Calculate 
the overall probability of wrist fracture per mission day 
by combining the two PDF’s. 
 
Step 1 was satisfied with accrued data describing skeletal 
wrist strength for the impact dynamics assumed aboard the 
ISS and from appropriate astronaut analog populations [7;8].  
The biomechanical model of step 2 is illustrated in Figure 
1. Differential equations of motion, described in detail in [2], 
were solved to determine the load on the wrist during an 
impact with an ISS wall. The velocity of impact was 
determined from four studies of the force resulting from a 
push-off of a space craft wall in a microgravity environment 
[9-13].The peak forces reported in these studies, along with 
the subjects’ masses were used with a derived force pulse 
width (1.1 ± 20%, based on the average push-off force 
duration in [9]) to estimate impact velocity. A distribution was 
developed from these data and from the solution of the 
biomechanical model for the peak force during an impact for 
subjects with an average mass of approximately 73 kg. The 
force was then scaled to a body mass that was based on 
anthropometric data from the astronaut corps. The calculated 
peak force was also modulated to account for the fact that 
impact force decreases with increasing elbow flexion. A 
uniform distribution of elbow flexion (150 – 180°) was used in 
our model and the average decrease in impact force per degree 
of flexion used was 1.4 ± 1.4 %/° [14-16].  
 
 
Figure 1. Biomechanical mass-spring-damper model for 
wrist impact. The total body mass minus the arm mass (mT)  
and arm mass (mA); the stiffness of the shoulder (kS) and wrist 
(kW); the damping characteristics of the shoulder (bS) and 
wrist (bW); and the displacement of mT (xT) and mA (xA) are 
shown.  
 
For step 3, a database of in-flight musculoskeletal injuries 
provided a means to estimate the loading incidence rate. Five 
of 219 musculoskeletal injuries during the 231,724.7 hours of 
in-flight operations by U.S. Astronauts have occurred at the 
wrist [17]. This equates to 5.18 x10-4 wrist injuries per day, 
which was used in our analyses, along with an estimated 10% 
standard deviation derived from expert opinion. Since the 
incidence rate only takes into account events where an injury 
could occur, the impact force was represented as a force which 
was capable of producing an injury. No data exists on injury 
capable force vs. nominal force. Instead, an assumption was 
made that the mean injury capable force is equal to the 90th 
percentile of the normal force. 
A logistic regression was performed to develop the 
transfer function of step 4. Terrestrial data was used to link 
estimates of FRI to fracture probability by comparing the 
binary condition of actual fractures to non-fractures, with 
reference to a set of appropriate controls and specified loading 
events [18]. The result of the regression was a sigmoidal curve 
that related FRI to probability of fracture [2].  
As described in step 5, A Monte Carlo simulation was 
performed to assess the likelihood of wrist fracture during a 6 
month ISS mission. The result of running the simulation 
100,000 times was the FRI distribution shown in Figure 2. It is 
noted that the 95th-percentile FRI does not exceed 0.5, 
indicating that the load is less than the bone strength most of 
the time. The PDF for probability of fracture is illustrated in 
Figure 3. The mean likelihood for wrist fracture is very low, 
although the uncertainty, as represented by the width of the 
standard deviation is significant. The results are also tabulated 
in Table 1.  
 
TABLE 1. SUMMARY OF RESULTS 
 
 
Mean 
Standard 
Deviation 
 
5% 
 
95% 
FRI 0.23 0.68 0.05 0.49 
Fracture 
Probability 1.2x10-5 6.4x10-5 1.8x10-13 3.2x10-5 
 
 
 
Figure 2. The FRI distribution used to calculate the 
probability of wrist fracture during an ISS mission. 
 
 
Figure 3. The probability distribution of the probability of 
wrist fracture during an ISS mission. 
 
2.2 Estimating the Level of Sleep Medication Use 
During ISS missions, difficulties with sleep affect more 
than half of all US crews. Mitigation strategies to help 
astronauts cope with the challenges of disrupted sleep patterns 
can have a substantial impact on vehicle specific consumable 
mass or volume or on the mission timeline. 
Developed in partnership with collaborators at the Air 
Force Research Laboratory and Institutes for Behavior 
Resources (IRB), Inc., the Sleep Disruption and Medical 
Intervention Forecasting (SDMIF) tool was designed to 
estimate the occurrence and impact of sleep disturbance with 
regard to mission planning and the need for medical 
interventions. The module concept (Figure 4) includes a 
representative mission sleep and wake schedule that was based 
on scenario design, mission parameters and historical patterns 
of events that effect astronaut sleep schedules. This 
information was used to estimate metrics representing the 
need for sleep, which were then compared to threshold values 
to diagnose the likelihood for treatment. The metrics were 
correlated to the likelihood that a consumable mitigation 
approach was used during a particular mission day. The 
specific steps used to accomplish this process are as follows: 
 
1) Generate a daily schedule of crew sleep opportunities for 
a simulated ISS increment 
2) Convert sleep opportunities to actual sleep times 
3) Generate a sleep quality factor 
4) Pass the sleep/wake period parameters to the Sleep, 
Activity, Fatigue, and Task Effectiveness (SAFTE) model 
to evaluate astronaut sleep intensity [19] 
5) Calculate the probability of taking a sleep medication 
based on the sleep intensity from the SAFTE output, and 
execute a bootstrap decision for sleep medication 
utilization. 
 
A Monte Carlo approach was used to integrate these functions 
over the defined parameter space.  
At the core of the ability to assess the need for sleep aids 
is the ability to generate realistic sleep/work schedules for ISS 
missions and to use those to calculate the level of sleep 
intensity, a measure of the need for sleep. 
 
 
Figure 4. Illustration of  the conceptual framework for 
predicting sleep disruption resulting in the need for a medical 
intervention.     
 
The mission parameter module generates realistic ISS 
mission schedules of sleep and wake times. The sleep/wake 
schedules include events that cause a shift in the sleep 
schedule (Shuttle, Soyuz and Progress Dockings and Extra 
Vehicular Activities) and were derived from historical planned 
and actual ISS mission schedules (Personal Communication 
with Lauren Leveton, 2008). The best available data on 
measured sleep patterns from past US space missions was 
used to model the actual amount of sleep obtained by 
astronauts in space and the quality of that sleep [20;21]. The 
quality of sleep depends upon the frequency and quantity of 
wakefulness, or interruptions, during a sleep period.  
The effects of sleep timing and duration and the influence 
of time of day (circadian effects) on performance are 
estimated using a deterministic model, modulated by the input 
parameters of the random schedule generator. The Sleep, 
Activity, Fatigue, and Task Effectiveness (SAFTE) Model, 
(IBR, Inc.) [19] was identified as an accurate and well-
established integration tool. This model was chosen for five 
reasons:  
 
1) It predicts performance in non-arbitrary units of 
performance effectiveness that relate directly to 
performance on a psychomotor vigilance task. 
2) It requires a minimum number of input variables. 
3) It has a method for reflecting the degrading effects of 
sleep fragmentation or sleep interruptions. 
4) It tracks changes in circadian phase based on changes in 
the work/rest schedule that commonly occur on ISS. 
5) It has been validated as an accurate predictor of risk in the 
work environment [22]. 
 
At the center of the model is a sleep reservoir which, along 
with the circadian rhythm and sleep inertia, determines 
performance effectiveness. With some minor modifications 
SAFTE was easily incorporated into our modeling approach to 
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provide estimates of sleep intensity for every sleep 
opportunity for a given ISS mission schedule. 
As defined in our general approach to modeling and in the 
estimate of wrist fracture probability, a functional 
transformation relation was needed to assess sleep aid use 
requirements from the estimate of sleep intensities. In this 
case, direct evidence of sleep aid use on ISS cannot be 
determined from observed data, as medication use for this 
condition is effectively voluntary and not explicitly tracked. In 
this case, estimates from subject matter experts at the Air 
Force Research Laboratory and Institutes for Behavior 
Resources, Inc. were used to estimate terrestrial based 
threshold levels suitable for defining the translation 
formulation. 
Figure 5 illustrates the predictive results from 5,000 
Monte Carlo trials of a simulated ISS increment utilizing the 
mission parameter program, with its associated distributions, 
and also distributions for sleep structure and sleep quality., In 
this case, the mean sleep medication use was predicted to be 
51 ± 39 (95% CI). For a six person crew, this corresponds to 
approximately 306 sleep aids per ISS increment. Estimates of 
this type are critical in the design and maintenance of the on 
orbit medical kit.  
 
 
Figure 5. Illustration of predicted sleep aid medication 
requirements per astronaut per ISS mission, incorporating 
shifts in the schedule and assuming terrestrial performance 
measures.   
3 DISCUSSION AND CONCLUSIONSS 
The need to estimate the likelihood of medical risk during 
space missions is quite evident. However the small number of 
space faring participants and the limited exposure time 
severely curtails using estimates of likelihood based solely on 
the frequency of the observed phenomena. In this effort a 
process based on well established PRA practices, augmented 
to address the unique responses of clinical events and their 
contributors, has been established and shown to produce 
informative assessments of critical mission scenarios. 
The ISS wrist fracture module predicts a relatively low 
nominal occurrence of traumatic fractures due to translational 
impacts on ISS, which qualitatively agrees with assessments 
of medical operations physicians. The model provides a much 
needed integration of the best available data for estimating the 
likelihood of a significant risk to crew and mission. It should 
be noted that the prediction uncertainty, as defined by the 
standard deviation, is relatively high and directly influences 
subsequent predictions of crew evacuation within the IMM 
model. 
The application of the modeling process to estimate the 
quantity of sleep aid medication use with respect to the 
specific ISS mission parameters represents a unique 
application of this form of risk modeling. Such efforts can 
directly benefit mission planners, the assessment of treatment 
strategies by medical operations personnel and the 
optimization of the in-flight medical kits. The critical 
limitation in this case is the lack of data that correlates the 
predicted sleep intensities with actual sleep aid use. Efforts to 
utilize research data to supplement in-flight clinical 
observations are underway to improve the predictive ability of 
this module. 
All modeling efforts require some form of validation and 
assessment of model credibility, and this is especially true of 
models that are used for decision making and mission 
planning. Each of these models is validated on a component 
basis, i.e. the components are rigorously validated and the 
integrated module is validated as data becomes available. Both 
the wrist fracture module and SDMIF have been used to 
estimate likelihoods from simplified terrestrial scenarios with 
acceptable success. Details of the validation process for these 
and other modules produced by our groups will be the subject 
of future publications.  
In conclusion, the use of a probabilistic approach, 
augmented from well established PRA practices, has been 
used to estimate the likelihood of fractures and sleep medicine 
use for astronauts on typical ISS missions. The models use 
well accepted deterministic modeling approaches to act as 
integrators of observed physiology, performance level and 
environment, which can contribute to the clinical risk. Such 
data fills a critical void in the assessment of risks to astronaut 
health and mission success.  
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provide HRP decision makers with a valuable source of information which is otherwise lacking. 
National Aeronautics and Space Administration
www.nasa.gov
ASSESSING THE LIKELIHOOD OF RARE
MEDICAL EVENTS IN ASTRONAUTS
Thursday, January 27, 2011, 10:00 AM – 12:15 PM
Jerry G. Myers, Jr., Ph.D NASA GRC
Beth E. Lewandowski, Ph.D NASA GRC 
John Brooker, NASA GRC
Aaron Weaver, Ph.D NASA GRC
National Aeronautics and Space Administration (NASA)
John H. Glenn Research Center (GRC)
1
National Aeronautics and Space Administration
www.nasa.gov 2
Integrated Medical Model (IMM)
• Probability and consequences of medical risks 
• Integrate best evidence in a quantifiable assessment of risk
• Identify medical resources necessary to optimize health and 
mission success
Likelihood of occurrence, 
probable severity of 
occurrence, and 
optimization of treatment 
and resources.
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IMM and External Modeling
• Forecasting rare medical concerns 
confounded by space travel
– Insufficient data (few or no occurrences)
– No clear correlation to terrestrial analog
• Examples
– Traumatic injury
• Skeletal fracture
– Renal stone
– Sleep medication use
• Hypothesis
– Much like an engineering problem, higher 
fidelity models can provide guidance in 
assessing medical incidence risk
• Requires
– Acceptable level of model maturity 
– Proper integration of model and observed 
data 
SPACE
Glenn Research Center – Human Research Program   
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"There are no new ideas. There are only new ways 
of making them felt."  Audre Lorde
• Process for Model Development
– Formulate the problem
• Clinical event of concern
• Context of space mission 
– Collect information / data
• Primary medical event metrics
• Biomechanics, physiology or performance 
models
• Parameter distributions
– Construct and validate model
• PRA (Monte Carlo) model to estimate 
medical event likelihood
• Component and whole model validation 
4
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EXAMPLE: LIKELIHOOD OF 
ISS WRIST FRACTURE
Lead By Example If You Expect Success
5
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Formulate the Problem: In Flight Fracture Risk
• Real and Present Concern: Skeletal Fracture
– Weakened Bones
– Off-nominal loading states
• Lack of In Flight Injuries
– Even at areas of high bone loss
• spine and proximal femur
• Fracture risk at wrist
– Some non-fracture in-flight injuries
• Many types suggested translation type injuries
– Load level and rate uncertain
• What is the fracture risk during a push off, 
impact or other sudden deceleration 
involving the wrist and shoulder after 
translation?
Lumbar
Spine
Proximal
Femur
Wrist
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Collect Information and Design Model
• Estimate the probability of loading 
event occurrence during each mission 
day
• Estimate the skeletal strength 
distribution at the wrist
• Skeletal loading 
– mass-spring-damper, biomech model 
of the wrist, arm and shoulder
– Identify distributions of all parameters
• Transfer function that translates FRI 
to a probability of fracture
– FRI = Loading/ Skeletal strength
• Monte Carlo simulation to integrate 
model and data components
– Output is a PDF of the probability of fracture 
per mission
7
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Wrist Fracture Probability Estimates
8
Probability of wrist fracture is relatively low, but not insignificant
Qualitatively agrees with the Med-Ops Physician assessments 
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EXAMPLE: RATE OF SLEEP 
AID NEED ON ISS
Lead By Example If You Expect Success
9
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Formulate the problem: Space Flight and Sleep
• Space flight induces reductions in sleep 
quality and quantity 
– Potential performance decrements 
• Primary mitigation
– Consolidated and efficient sleep
• Power naps
• Extended sleep opportunities
• Impacted by scheduling and 
environmental factors
– Medications or sleep aids
• Medication usage rates not explicitly 
known
• Worse Case ISS Mission 
– 6 crew, 2 pills a night, 0.5 years = 2K doses 
• What are the rates of medical 
intervention resulting from low sleep 
quality and duration?
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Sleep Disruption- Medical Intervention Forecasting 
(SDMIF) Tool
• Derive realistic daily schedule
– Crew sleep opportunities
– Crew sleep time
– Sleep quality
• Utilize validated modeling of sleep and 
performance
– SAFTE proprietary process 
• Accurately reflects the degrading effects 
of changes in circadian phase, sleep 
fragmentation or sleep interruptions
• Calculate sleep intensity from the 
SAFTE output
• Execute a bootstrap decision for sleep 
medication utilization
– Translation function derived from Air 
Force Research Laboratory and 
Institutes for Behavior Resources, Inc. 
subject matter experts 
Define Mission
Work and Sleep
Timelines
Calculate Sleep & 
Performance
Metrics
PDF of Mission
Sleep Medication Use
Correlate Sleep
Metric and 
Sleep Aid Use
Monte Carlo Simulation
Sleep, 
Activity, 
Fatigue, and 
Task
Effectiveness
(SAFTE™) Model
IBR, Inc.
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SDMIF Example Output for an ISS Mission
Estimated mean rate of sleep aid use is 1/3rd that of the WCS estimate
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Assessing Acceptability of the Models
• Chief factor is an acceptable V&V process
– Complicated by limited in-flight data
– Relies on systematic use of SME’s and multiple validation 
approaches to balance limits in direct comparative evidence  
• Models related to medical events used to inform Space 
Flight Operations and Planning
– Must exhibit a high level of Credibility for the intended use
– Must have their Credibility assessed over multiple factors
National Aeronautics and Space Administration
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V&V? Its Really About Model Credibility!
Achieving a high level of belief or trust in the model
• NASA-STD-7009
– Standard for Models and 
Simulations (M&S)
• M&S Development 
– Verification 
– Validation 
• M&S Operations 
– Input Pedigree 
– Results Uncertainty 
– Results Robustness 
• Supporting Evidence 
– Use History
– M&S Management 
– People Qualifications
14
Both the Wrist Fracture Model and 
SDMIF are undergoing component 
wise and full function credibility 
assessment 
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Let’s Review
• IMM utilizes external modules to 
supplement observed data
– Two examples: Bone Fracture and 
Sleep Disruption
– Others
• Renal stones, head and neck injuries
• External modules
– Utilize PRA concepts and tools to 
develop higher fidelity probabilistic 
models
– Development invokes
• Flexible modeling practices
• Well vetted existing models
• Concepts to address confounding 
contributions to the risk 
15
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QUESTIONS
“The most important questions of life are indeed, for the most part, 
really only problems of probability.” ~Pierre Simon Laplace 
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